Category: Outset

Outset Medical (NASDAQ: OM), a medical technology company, reported second-quarter earnings for 2024 that missed market expectations, primarily due to a slower ramp-up of its TabloCart product and an extended sales cycle. Despite these challenges, the company highlighted several positive aspects of its performance, such as strong treatment sales and…